{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-008275","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.833315+00:00","generated_at":"2026-05-26T03:30:48.911936+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Glucotrack appoints diabetes expert Dr. Guillermo Umpierrez to Medical Advisory Board","bullets":["Dr. Umpierrez, Professor of Medicine at Emory and past ADA president for Medicine & Science, joins effective immediately.","He will provide strategic guidance as Glucotrack advances its long-term implantable CBGM system through clinical development.","Glucotrack's CBGM has 3-year sensor life, no wearable component, and measures blood glucose directly to reduce lag time.","CEO Paul Goode cites Dr. Umpierrez's clinical and research expertise as valuable for upcoming human trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-008275","json":"https://secwatch.observer/filing/0001493152-25-008275.json","markdown":"https://secwatch.observer/filing/0001493152-25-008275.md","text":"https://secwatch.observer/filing/0001493152-25-008275.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225008275/0001493152-25-008275-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225008275/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:30:48.911936+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}